Volume 20, Number 1—January 2014
CME ACTIVITY - Research
Raw Milk Consumption among Patients with Non–Outbreak-related Enteric Infections, Minnesota, USA, 2001–2010
Table 1
Demographic characteristics of patients with domestically acquired, sporadic enteric infections, Minnesota, 2001–2010
Pathogen |
Patients reporting raw milk consumption |
Patients denying raw milk consumption |
|||||
No. patients |
Median age, y (range) |
Male, % |
No. patients |
Median age, y (range) |
Male, % |
||
Campylobacter spp. |
407 |
18 (<1–92)* |
63.9* |
6,340 |
33 (<1–96) |
56.9 |
|
Cryptosporidium spp. |
53 |
8 (1–74)* |
52.8 |
1,689 |
21 (<1–101) |
45.6 |
|
Escherichia coli O157 |
19 |
5 (<1–63)* |
63.2 |
1,050 |
16 (<1–92) |
46.3 |
|
Non-O157 Shiga toxin–producing E. coli |
12 |
4 (1–61) |
66.7 |
342 |
18 (<1–88) |
46.3 |
|
Salmonella spp. |
39 |
16 (1–78)* |
59.0 |
4,388 |
28 (<1–98) |
46.6 |
|
Total | 530 | 17 (<1–92)* | 62.6* | 13,809 | 29 (<1–101) | 51.3 |
*Significantly different (p<0.05) from persons who denied raw milk consumption.